Hunan Jingfeng Pharmaceutical Co Ltd Class A 000908
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥3.59
- Day Range
- ¥3.41–3.58
- 52-Week Range
- ¥0.72–5.07
- Bid/Ask
- ¥0.00 / ¥3.41
- Market Cap
- ¥3.00 Bil
- Volume/Avg
- 117.3 Mil / 37.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.60
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Hunan Jingfeng Pharmaceutical Co Ltd is engaged in the manufacturing of pharmaceutical products in China. The company offers Chemical medicine, Biological medicine, and Traditional Chinese medicine. Some of its products include Lemai Wan, Analgesic, Fuping Capsules, and Tongdi Capsules among others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Value
- Total Number of Employees
- 572
- Website
- http://www.jfyiyao.com
Comparables
Valuation
|
Metric
|
000908
|
002393
|
600285
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 26.62 | 20.28 |
Price/Book Value | — | 0.86 | 4.75 |
Price/Sales | 6.60 | 3.39 | 3.64 |
Price/Cash Flow | — | 18.01 | 17.45 |
Price/Earnings
000908
002393
600285
Financial Strength
|
Metric
|
000908
|
002393
|
600285
|
|---|---|---|---|
Quick Ratio | 0.11 | 2.89 | 0.77 |
Current Ratio | 0.17 | 3.50 | 1.08 |
Interest Coverage | −4.33 | 169.67 | — |
Quick Ratio
000908
002393
600285
Profitability
|
Metric
|
000908
|
002393
|
600285
|
|---|---|---|---|
Return on Assets (Normalized) | −22.46% | 2.80% | 13.60% |
Return on Equity (Normalized) | −1,863.72% | 3.38% | 23.41% |
Return on Invested Capital (Normalized) | −42.67% | 1.92% | 21.59% |
Return on Assets
000908
002393
600285
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Qjbqfcbqwy | Bbys | $790.4 Bil | |||
| Johnson & Johnson
JNJ
| Sbjcntwd | Vrcmz | $388.5 Bil | |||
| AbbVie Inc
ABBV
| Kvpxcylx | Jwxs | $344.1 Bil | |||
| Merck & Co Inc
MRK
| Fvjvdyyp | Vdy | $288.2 Bil | |||
| Roche Holding AG ADR
RHHBY
| Qgbvrcylp | Dcgrc | $258.7 Bil | |||
| AstraZeneca PLC ADR
AZN
| Wllcmttvt | Hbqdh | $242.3 Bil | |||
| Novartis AG ADR
NVS
| Tcdjsnc | Ydb | $234.2 Bil | |||
| Amgen Inc
AMGN
| Jjkdxvksh | Qtbdd | $173.4 Bil | |||
| Pfizer Inc
PFE
| Jhsczsj | Ymkd | $164.8 Bil | |||
| Sanofi SA ADR
SNY
| Ldzgqcl | Rjm | $144.3 Bil |
United States